NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 213 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,164,000 | -76.6% | 10,000 | -66.7% | 0.04% | -77.4% |
| Q2 2021 | $4,974,000 | -51.7% | 30,000 | -49.6% | 0.16% | -58.6% |
| Q4 2020 | $10,300,000 | +132.2% | 59,500 | +86.9% | 0.37% | +63.3% |
| Q3 2020 | $4,435,000 | -47.7% | 31,838 | -55.2% | 0.23% | -71.9% |
| Q2 2020 | $8,482,000 | +324.1% | 71,000 | +255.0% | 0.82% | +244.3% |
| Q1 2020 | $2,000,000 | -81.5% | 20,000 | -78.3% | 0.24% | -75.1% |
| Q4 2019 | $10,814,000 | +209.0% | 92,000 | +2.2% | 0.95% | +36.1% |
| Q4 2018 | $3,500,000 | +2.3% | 90,000 | +50.0% | 0.70% | -2.8% |
| Q3 2018 | $3,420,000 | -28.6% | 60,000 | 0.0% | 0.72% | -62.6% |
| Q2 2018 | $4,791,000 | +117.8% | 60,000 | +5.4% | 1.92% | +137.3% |
| Q4 2014 | $2,200,000 | – | 56,900 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |